Post-COVID-19 Vaccine Parosmia: A Case Report

We present the case of a healthy 38-year-old male who developed parosmia following a second dose of AstraZeneca with a negative nasal swab of coronavirus disease 2019 (COVID-19) infection. The patient noted parosmia that started suddenly after one week of receiving the second dose of AstraZeneca wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Zamzami, Osama S, Kabli, Abdulrahman F, Alhothali, Ammar S, Alhothali, Omar S, Alharbi, Tayil A, Bahakim, Abdullah K, Marglani, Osama A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747983/
https://www.ncbi.nlm.nih.gov/pubmed/35028203
http://dx.doi.org/10.7759/cureus.20292
_version_ 1784630963583582208
author Zamzami, Osama S
Kabli, Abdulrahman F
Alhothali, Ammar S
Alhothali, Omar S
Alharbi, Tayil A
Bahakim, Abdullah K
Marglani, Osama A
author_facet Zamzami, Osama S
Kabli, Abdulrahman F
Alhothali, Ammar S
Alhothali, Omar S
Alharbi, Tayil A
Bahakim, Abdullah K
Marglani, Osama A
author_sort Zamzami, Osama S
collection PubMed
description We present the case of a healthy 38-year-old male who developed parosmia following a second dose of AstraZeneca with a negative nasal swab of coronavirus disease 2019 (COVID-19) infection. The patient noted parosmia that started suddenly after one week of receiving the second dose of AstraZeneca with no association with other symptoms. The patient has still not recovered from his parosmia until the publication of this article. The olfactory disorder was confirmed using a validated questionnaire for parosmia assessment and examination by rhinoscopy. Parosmia is a rare side effect of COVID-19, and its pathophysiological mechanism is still unknown. More research in the future is needed to know the association of parosmia with COVID-19 vaccine.
format Online
Article
Text
id pubmed-8747983
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-87479832022-01-12 Post-COVID-19 Vaccine Parosmia: A Case Report Zamzami, Osama S Kabli, Abdulrahman F Alhothali, Ammar S Alhothali, Omar S Alharbi, Tayil A Bahakim, Abdullah K Marglani, Osama A Cureus Internal Medicine We present the case of a healthy 38-year-old male who developed parosmia following a second dose of AstraZeneca with a negative nasal swab of coronavirus disease 2019 (COVID-19) infection. The patient noted parosmia that started suddenly after one week of receiving the second dose of AstraZeneca with no association with other symptoms. The patient has still not recovered from his parosmia until the publication of this article. The olfactory disorder was confirmed using a validated questionnaire for parosmia assessment and examination by rhinoscopy. Parosmia is a rare side effect of COVID-19, and its pathophysiological mechanism is still unknown. More research in the future is needed to know the association of parosmia with COVID-19 vaccine. Cureus 2021-12-09 /pmc/articles/PMC8747983/ /pubmed/35028203 http://dx.doi.org/10.7759/cureus.20292 Text en Copyright © 2021, Zamzami et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Zamzami, Osama S
Kabli, Abdulrahman F
Alhothali, Ammar S
Alhothali, Omar S
Alharbi, Tayil A
Bahakim, Abdullah K
Marglani, Osama A
Post-COVID-19 Vaccine Parosmia: A Case Report
title Post-COVID-19 Vaccine Parosmia: A Case Report
title_full Post-COVID-19 Vaccine Parosmia: A Case Report
title_fullStr Post-COVID-19 Vaccine Parosmia: A Case Report
title_full_unstemmed Post-COVID-19 Vaccine Parosmia: A Case Report
title_short Post-COVID-19 Vaccine Parosmia: A Case Report
title_sort post-covid-19 vaccine parosmia: a case report
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747983/
https://www.ncbi.nlm.nih.gov/pubmed/35028203
http://dx.doi.org/10.7759/cureus.20292
work_keys_str_mv AT zamzamiosamas postcovid19vaccineparosmiaacasereport
AT kabliabdulrahmanf postcovid19vaccineparosmiaacasereport
AT alhothaliammars postcovid19vaccineparosmiaacasereport
AT alhothaliomars postcovid19vaccineparosmiaacasereport
AT alharbitayila postcovid19vaccineparosmiaacasereport
AT bahakimabdullahk postcovid19vaccineparosmiaacasereport
AT marglaniosamaa postcovid19vaccineparosmiaacasereport

Ejemplares similares